Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix-IPV/Hib in Russian children
NCT02858440Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Sep 2016; status: completed.
02
Drugs
diphtheria + tetanus + acellular pertussis + inactivated poliomyelitis + Haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT02858440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858440.